医药合作协议：2020-2026

本报告对全球医药和生物技术产业的合作协议进行了全面分析。报告面向业务拓展、授权和策略专业人士，清楚阐述了企业如何建立合作关係、协商财务条款以及在研发和商业化合作中明确责任。

本报告彙编了自2020年以来签署的合作协议的详细合约记录，并总结了合作趋势、财务结构以及主要签署方的分析。每份协议均包含指向线上合约记录的链接，并在条件允许的情况下提供原始合约文件，从而直接展现影响行业合作关係的合约内容。

无论是在评估潜在合作伙伴、对标合约条款，还是对合作策略进行尽职调查，本报告都能提供所需的数据和合约层面的信息，以支持更明智的合作决策。

主要优势

• 显着缩短研究时间

无需搜寻多个资料库、新闻稿和监管文件，即可存取统一的合作协议资料库。

• 合作协议结构基准分析

您可以了解各公司如何建构合作关係，包括开发角色、财务安排和商业化责任分担。

• 财务合约条款分析

仔细审查有关预付款、里程碑付款和特许权使用费结构的可用数据，并对类似协议的财务价值进行基准分析。

• 存取实际合约文件

在适用情况下，本报告直接连结到美国证券交易委员会 (SEC) 的文件，方便您查看关键联合开发协议背后的详细合约条款。

• 识别最活跃的合作协议签署公司

识别哪些製药和生技公司在合作活动中处于领先地位，并分析其合作策略。

• 追踪合作领域的市场趋势

依公司、治疗领域和技术类型分析合作活动，以了解合作策略的演变。

目录

摘要整理

第一章：引言

第二章：合作协议趋势

• 合作协议的定义
• 2020年以来的合作协议趋势
  • 依年份
  • 依研发阶段
  • 依行业
  • 依治疗领域
  • 依技术
  • 最活跃的公司
• 签订合作协议的原因
• 合作协议的未来

第三章：合作协议架构概述

• 合作协议的结构

第四章：主要合作协议

• 主要合作协议：依金额排序

第五章 最活跃的25家合作公司

• 最活跃的25家合作公司

第六章 合作公司名录：含合约

• 合作协议：含合约
• 合约名录
• 合约名录 - 依公司（A-Z）排序
• 合约名录 - 依治疗领域排序
• 合约名录 - 依技术排序
• 关于Biopharma Research Ltd
• 当前合作关係
• 当前合约
• 近期合作报告标题

Benchmark Collaboration Partnerships Across the Global Biopharma Industry

Free report sample

The Collaboration Deals in Pharmaceuticals report provides a comprehensive analysis of partnership agreements across the global pharmaceutical and biotechnology industry. Designed for business development, licensing, and strategy professionals, the report delivers a clear view of how companies structure collaboration alliances, negotiate financial terms, and share responsibilities across R&D and commercialization partnerships.

Drawing on collaboration deals announced since 2020, the report compiles detailed deal records alongside analysis of partnering trends, financial structures, and leading dealmakers. Each transaction links to an online deal record and, where available, the original contract document-giving users direct insight into the agreements that shape industry partnerships.

Whether you are evaluating a potential partner, benchmarking deal terms, or performing due diligence on collaboration strategies, this report provides the data and contract-level visibility needed to support more informed partnership decisions.

Key Benefits

• Save Significant Research Time

Access a consolidated database of collaboration deals instead of searching multiple databases, press releases, and regulatory filings.

• Benchmark Collaboration Deal Structures

Understand how companies structure collaborative partnerships, including development roles, financial arrangements, and commercialization responsibilities.

• Analyze Financial Deal Terms

Review available data on upfront payments, milestone payments, and royalty structures to benchmark the financial value of comparable deals.

• Access Real Contract Documents

Where available, the report links directly to SEC-filed agreements, allowing you to review the detailed contractual terms behind major collaboration deals.

• Identify the Most Active Collaboration Dealmakers

See which pharmaceutical and biotechnology companies are leading collaboration activity and analyze their partnership strategies.

• Track Market Trends in Collaboration Partnerships

Analyze dealmaking activity across companies, therapeutic areas, and technology types to understand how collaboration strategies are evolving.

What's Included in the Report

Analysis of collaboration dealmaking trends since 2020

Overview of collaboration deal structures and partnering models

Review of the leading collaboration deals by disclosed value

Profiles of the most active collaboration dealmakers

A comprehensive deal directory organized by company, therapeutic area, and technology type

Links to online deal records and contract documents where available

Due Diligence Insights from Real Agreements

By reviewing actual collaboration agreements, the report helps you evaluate key contractual elements such as:

• Rights granted or optioned
• Financial payment structures
• Exclusivity provisions
• Intellectual property ownership
• Development, manufacturing, and commercialization responsibilities
• Deal duration and termination provisions
• Why This Report Matters
• Collaboration partnerships are a cornerstone of innovation in the pharmaceutical and biotechnology industries. Understanding how these alliances are structured-and how financial and operational responsibilities are negotiated-can significantly improve partnership outcomes.
• This report provides the real-world data, financial benchmarking, and contract insight needed to structure better collaboration agreements and negotiate more effectively.

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in collaboration dealmaking

• 2.1. Introduction
• 2.2. Definition of collaboration deal
• 2.3. Trends in collaboration deals since 2020
  • 2.3.1. Collaboration dealmaking by year
  • 2.3.2. Collaboration dealmaking by phase of development
  • 2.3.3. Collaboration dealmaking by industry sector
  • 2.3.4. Collaboration dealmaking by therapy area
  • 2.3.5. Collaboration dealmaking by technology type
  • 2.3.6. Collaboration dealmaking by most active company
• 2.4. Reasons for entering into collaboration partnering deals
• 2.5. The future of collaboration deals

Chapter 3 - Overview of collaboration deal structure

• 3.1. Introduction
• 3.2. Collaboration agreement structure

Chapter 4 - Leading collaboration deals

• 4.1. Introduction
• 4.2. Top collaboration deals by value

Chapter 5 - Top 25 most active collaboration dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active collaboration dealmakers

Chapter 6 - Collaboration deals including contracts directory

• 6.1. Introduction
• 6.2. Collaboration deals with contracts
• Deal directory
• Deal directory - collaboration dealmaking by companies A-Z
• Deal directory - collaboration dealmaking by therapy area
• Deal directory - collaboration dealmaking by technology type
• About Biopharma Research Ltd
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of collaboration deals
• Figure 2: Trends in collaboration deal announcements, 2020-2026
• Figure 3: Collaboration deals signed at each phase of development
• Figure 4: Collaboration deals by industry sector
• Figure 5: Collaboration deals by therapy area
• Figure 6: Collaboration deals by technology type
• Figure 7: Top 25 most active collaboration dealmakers
• Figure 8: Top collaboration deals by value
• Figure 9: Most active collaboration dealmakers